AQP4 and optic neuritis: Importantly, satralizumab transfer to umbilical cord blood, infant serum, or breast milk was not observed.<h4>Case presentation</h4>A 37-year-old Japanese female developed anti-aquaporin 4 antibody-positive NMOSD with left optic neuritis.